Elanco Animal Health Inc SEC filings ELAN
Elanco Animal Health Inc has 1,015 filings in SEC EDGAR's recent list, going back to Sep 19, 2018. Its latest annual report, Form 10-K, was filed on Feb 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 19, 2023 | — |
| S-8 | Employee stock plan registration | May 19, 2022 | — |
| S-8 | Employee stock plan registration | Aug 9, 2021 | — |
| 424B7 | Filing | Dec 2, 2020 | — |
| FWP | Free writing prospectus | Dec 1, 2020 | — |
| 424B7 | Filing | Nov 30, 2020 | — |
| 424B5 | Prospectus supplement | Jan 24, 2020 | — |
| 424B5 | Prospectus supplement | Jan 24, 2020 | — |
| FWP | Free writing prospectus | Jan 23, 2020 | — |
| 424B5 | Prospectus supplement | Jan 21, 2020 | — |
| 424B5 | Prospectus supplement | Jan 21, 2020 | — |
| S-3ASR | Automatic shelf registration | Jan 21, 2020 | — |
| 424B3 | Prospectus | Jun 17, 2019 | — |
| S-4/A | Filing | Jun 12, 2019 | — |
| S-4 | Registration for a merger or exchange | May 30, 2019 | — |
| 424B3 | Prospectus | May 29, 2019 | — |
| S-4 | Registration for a merger or exchange | May 17, 2019 | — |
| 424B3 | Prospectus | Mar 5, 2019 | — |
| S-4/A | Filing | Feb 22, 2019 | — |
| S-4 | Registration for a merger or exchange | Feb 8, 2019 | — |
| 424B4 | Prospectus | Sep 21, 2018 | — |
| S-8 | Employee stock plan registration | Sep 20, 2018 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELAN (NYSE)
- Fiscal year ends
- December 31
- Headquarters
- Indianapolis, IN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1739104
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.